Premium
Oral Candida and Entembacteriaceae in HIV‐1 infection: correlation with clinical candidiasis and antimycotic therapy
Author(s) -
SchmidtWesthausen Andrea,
Schiller ReinholdAndreas,
Pohle Hans Dieter,
Reichart Peter A.
Publication year - 1991
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.1991.tb00405.x
Subject(s) - enterobacteriaceae , microbiology and biotechnology , mycosis , medicine , candida albicans , biology , immunology , escherichia coli , biochemistry , gene
Oral swabs of 73 HIV‐1 infected men (32 under conditions of antimycotic treatment (43,8%)) and 58 controls were cultured for Candida species and Enterobacteriaceae. In Group A without antimycotics, yeasts were isolated from 35/41 swabs (85,4%) (range 2× 10 6 −4 × 10 6 cfu/ml). In Group B with antimycotics, yeasts were cultured from 27/32 swabs (84,4%) (4×10 1 −1 × 10 6 cfu/ml). Oral Enterobacteriaceae (o.e.) were grown from 22% of the swabs of both Group A (2× 10 1 −2 × 10 6 cfu/ml) and Group B(4×10 6 −1,6× 10 6 cfu/ml). Growth of o.e. and yeasts (2 × 10 6 −4 × 10 6 cfu/ml). Correlation between yeasts and o. e. were isolated in 14% (2×10 1 −6,4 × 10 6 cfu/ml). Correlation between yeasts species to local and systemic treatment deserves further investigations.